Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria

Drug and Alcohol Dependence

Volumn 153, Issue , 2015, Pages 167-172

  Ben Taleb, Ziyad ^a   Ward, Kenneth D ^b,c   Asfar, Taghrid ^c,d   Bahelah, Raed ^a,e   Maziak, Wasim ^a,c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c SYRIAN CENTER FOR TOBACCO STUDIES   (Syrian Arab Republic)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ADEN   (Yemen)

Author keywords

Adherence; Cessation; Cigarettes; Developing countries; Smoking

Indexed keywords

NICOTINE; PLACEBO; NICOTINE GUM;

ADULT; ARTICLE; BEHAVIOR THERAPY; DEVELOPING COUNTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; SYRIAN ARAB REPUBLIC; TOBACCO DEPENDENCE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; POVERTY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; YOUNG ADULT;

NICOTIANA TABACUM;

ADULT; AMBULATORY CARE FACILITIES; BEHAVIOR THERAPY; DEVELOPING COUNTRIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; POVERTY; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; SYRIA; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84937642495     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.05.038     Document Type: Article

References (43)

1. Aboaziza E., Eissenberg T. Waterpipe tobacco smoking: what is the evidence that it supports nicotine/tobacco dependence?. Tob. Control 2014, 24:44-53.
2. The Tobacco Dependence Treatment Handbook: A Guide to Best Practices 2003, Guilford Press, New York, NY. D.B. Abrams, R. Niaura (Eds.).
3. Alterman A.I., Gariti P., Cook T.G., Cnaan A. Nicodermal patch adherence and its correlates. Drug Alcohol Depend. 1999, 53:159-165.
4. Asfar T., Vander Weg M.W., Maziak W., Hammal F., Eissenberg T., Ward K.D. Outcomes and adherence in Syria's first smoking cessation trial. Am. J. Health Behav. 2008, 32:146-156.
5. Asfar T., Al-Ali R., Ward K.D., Vander Weg M.W., Maziak W. Are primary health care providers prepared to implement an anti-smoking program in Syria?. Patient Educ. Couns. 2011, 85:201-205.
6. Berg C.J., Ahluwalia J.S., Cropsey K. Predictors of adherence to behavioral counseling and medication among female prisoners enrolled in a smoking cessation trial. J. Correct Health Care 2013, 19:236-247.
7. Biener L., Abrams D.B. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991, 10:360-365.
8. Cooper T.V., DeBon M.W., Stockton M., Klesges R.C., Steenbergh T.A., Sherrill-Mittleman D., Jennings L.C., Johnson K.C. Correlates of adherence with transdermal nicotine. Addict. Behav. 2004, 29:1565-1578.
9. Darredeau C., Barrett S.P. The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers. Hum. Psychopharmacol. 2010, 25:577-581.
10. Erikson M., Mackay J., Ross H. The Tobacco Atlas 2013, American Cancer Society, New York, NY. fourth ed.
11. Fiore M.C., Jaen C.R., Baker T.B., Bailey W.C., Bennett G., Benowitz N.L., Christiansen B.A., Connell M., Curry S.J., Dorfman S.F.A. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service Report. Am. J. Prev. Med. 2008, 35:158-176.
12. Hammal F., Mock J., Ward K.D., Eissenberg T., Maziak W. A pleasure among friends: how narghile (waterpipe) smoking differs from cigarette smoking in Syria. Tob. Control 2008, 17:e3.
13. Hays J.T., Leischow S.J., Lawrence D., Lee T.C. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob. Res. 2010, 12:574-581.
14. Heatherto, n T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
15. Hollands G.J., Sutton S., McDermott M.S., Marteau T.M., Aveyard P. Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care. Nicotine Tob. Res. 2013, 15:1537-1544.
16. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43:289-294.
17. Jha P., Chaloupka F.J., Moore J. Tobacco addication. Disease Control Priorities in Developing Countries 2006, 869-886. Oxford University Press and World Bank, Washington, DC, New York, NY. D.T. Jamison, J.G. Breman, A.R. Measham (Eds.).
18. Klesges R.C., Brown K., Pascale R.W., Murphy M., Williams E., Cigrang J.A. Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace. Health Psychol. 1988, 7:575-589.
19. Kopjar B., Sales A.E., Piñeros S.L., Sun H., Li Y.F., Hedeen A.N. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. Am. J. Cardiol. 2003, 92:1106-1108.
20. Maziak W. The waterpipe: a new way of hooking youth on tobacco. Am. J. Addict. 2014, 23:103-107.
21. Maziak W., Eissenberg T., Klesges R.C., Keil U., Ward K.D. Adapting smoking cessation interventions for developing countries: a model for the Middle East. Int. J. Tuberc. Lung Dis. 2004, 8:403-413.
22. Maziak W. Health in the middle East. BMJ 2006, 333:815-816.
23. Mizes J.S., Sloan D.M., Segraves K., Spring B., Pingitore R., Kristeller J. The influence of weight-related variables on smoking cessation. Behav. Ther. 1998, 29:371-385.
24. Nachega J.B., Hislop M., Dowdy D.W., Lo M., Omer S.B., Regensberg L., Chaisson R.E., Maartens G. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J. Acquir. Immune Defic. Syndr. 2006, 43:78-84.
25. Okuyemi K.S., Zheng H., Guo H., Ahluwalia J.S. Predictors of adherence to nicotine gum and counseling among African-American light smokers. J. Gen. Intern. Med. 2010, 25:969-976.
26. Patterson F., Jepson C., Kaufmann V., Rukstalis M., Audrain-McGovern J., Kucharski S., Lerman C. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug Alcohol Depend. 2003, 72:123-131.
27. Post A., Gilljam H., Rosendahl I., Bremberg S., Rosaria Galanti M. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction 2010, 105:740-746.
28. Radloff L.D. The CES-D: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
29. Ruddy K.J., Partridge A.H. Adherence with adjuvant hormonal therapy for breast cancer. Ann. Oncol. 2009, 20:401-402.
30. Shiffman S., Sweeney C.T., Ferguson S.G., Sembower M.A., Gitchell J.G. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10 week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin. Ther. 2008, 30:1852-1858.
31. Stein M., Cantrell C., Sokol M., Eaddy M., Shah M. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatr. Serv. 2006, 57:673-680.
32. Thomas J.L., Jones G.N., Scarinci I.C., Mehan D.J., Brantley P.J. The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. The Center for Epidemiologic Studies-Depression. Int. J. Psychiatry Med. 2001, 31:25-40.
33. Timberlake D.S. A latent class analysis of nicotine-dependence criteria and use of alternate tobacco. J. Stud. Alcohol Drugs 2008, 69:709-717.
34. Tomar S.L., Alpert H.R., Connolly G.N. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys. Tob. Control 2010, 19:104-109.
35. Velicer W.F., Diclemente C.C., Rossi J.S., Prochaska J.O. Relapse situations and self-efficacy: an integrative model. Addict. Behav. 1990, 15:271-283.
36. Ward K.D., Asfar T., Al Ali R., Rastam S., Weg M.W.V., Eissenberg T., Maziak W. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction 2013, 108:394-403.
37. Ward K.D., Eissenberg T., Rastam S., Asfar T., Mzayek F., Fouad M.F., Hammal F., Mock J., Maziak W. The tobacco epidemic in Syria. Tob. Control 2006, 15(Suppl. 1):i24-i29.
38. World Bank Tobacco Control at Glance 2010, Available at: 〈http://siteresources.worldbank.org/INTPH/Resources/376086-1238076532997/TobaccoControl2010Nov15.pdf〉 (accessed January 14th, 2015).
39. World Health Organization (WHO) FCTC/COP4(8): Guidelines for Implementation of Article 14 of the WHO Framework Convention on Tobacco Control 2010, Available at: 〈http://www.who.int/fctc/protocol/guidelines/adopted/article_14/en/index.html〉 (accessed on 17 December, 2014).
40. World Health Organization Report on the Global Tobacco Epidemic. The MPOWER Package 2013, Available at: 〈http://www.who.int/tobacco/global_report/2013/en/〉.(accessed on 2 December, 2014).
41. World Health Organization Report on the Global Tobacco Epidemic: Country Profile. Syrian Arab Republic 2013, Available at: 〈http://www.who.int/tobacco/surveillance/policy/country_profile/syr.pdf〉.(accessed on 22 April 2015).
42. Zimet G.D., Dahlem N.W., Zimet S.G., Farley G.K. The multidimensional scale of perceived social support. J. Pers. Assess. 1988, 52:30-41.
43. Zimet G.D., Powell S.S., Farley G.K., Werkman S., Berkoff K.A. Psychometric characteristics of the multidimensional scale of perceived social support. J. Pers. Assess. 1990, 55:610-617.